Back to Boston Trust Walden Corp

CHE
Showing 8 of 29 quarters

Position history for Boston Trust Walden Corp's holdings in CHEMED CORP NEW

Boston Trust Walden Corp holds 205,197 shares of CHE (CHEMED CORP NEW), worth $77.5M as of 2026-Q1. The position was decreased (-7.3% shares). CHE represents 0.6% of Boston Trust Walden Corp's portfolio.

Current Value

$77.5M

Current Shares

205,197

Total Value Change

-$42.6M

Total Shares Change

-16,243

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
205,197
-7.3%
$77.5M0.6%$424.16
0
2025-Q4
Decreased
221,241
-5.6%
$94.7M0.7%$430.82
0
2025-Q3
Decreased
234,466
-5.2%
$105M0.8%$451.51
0
2025-Q2
Increased
247,434
+0.4%
$120.5M0.9%$557.82
42
2025-Q1
Increased
246,351
+1.7%
$151.6M1.1%$603.50
49
2024-Q4
Increased
242,172
+10.0%
$128.3M0.9%$525.44
47
2024-Q3
Decreased
220,067
-0.6%
$132.3M0.9%$595.79
0
2024-Q2
Increased
221,440
+5.3%
$120.1M0.9%$539.17
45

Other major holders of CHE: VANGUARD GROUP INC, BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used